生物谷29 天
Clin Cancer Res：科学家对药物重新定向或有望治疗非小细胞肺癌患者
近日，一篇发表在国际杂志Clinical Cancer Research上题为“Phase 1/2 trial of XPO1 inhibitor selinexor plus docetaxel in previously treated, advanced KRAS mutant non-small cell lung ...